MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, GALT has $19,532K in assets. $145,727K in debts. $17,720K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
242.04%
Quick Ratio
242.04%
Cash Ratio
220.67%
Debt to Asset Ratio
746.09%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Other
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Borrowing and accrued interest u...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
17,720
Prepaid expenses and other current assets
1,716
Total current assets
19,436
Other
96
Total assets
19,532
Accounts payable
3,245
Accrued expenses
4,722
Current portion of convertible notes payable and accrued interest, net of debt discounts related party (note 5)
0
Current portion of derivative liabilities (note 6)
0
Accrued dividends payable
63
Total current liabilities
8,030
Convertible notes payable and accrued interest, net of debt discounts related party (note 5)
32,702
Derivative liabilities (note 6)
3,962
Borrowing and accrued interest under convertible line of credit, net of debt discount related party (note 10)
101,033
Total liabilities
145,727
Series c 6 super dividend redeemable convertible preferred stock 1,000 shares authorized, 176 issued and outstanding at december 31, 2025 and 2024, redemption value 7,966,000, liquidation value 1,760,000 at december 31, 2025
1,723
Series a 12 convertible preferred stock 1,742,500 shares authorized, 1,210,000 and 1,235,000 issued and outstanding at december 31, 2025 and 2024, respectively, liquidation value 1,210,000 at december 31, 2025
490
Common stock, 0.001 par value 150,000,000 shares authorized at december 31, 2025 and 2024, 65,201,995 and 63,157,235 issued and outstanding at december 31, 2025 and 2024, respectively
65
Additional paid-in capital
304,073
Accumulated deficit
-432,546
Total stockholders deficit
-127,918
Total liabilities, redeemable convertible preferred stock and stockholders deficit
19,532
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$17,720K Prepaid expenses andother current assets$1,716K Total current assets$19,436K Other$96K Total assets$19,532K Accumulated deficit-$432,546K Total liabilities,redeemable convertible...$19,532K Total stockholdersdeficit-$127,918K Additional paid-in capital$304,073K Series a 12 convertiblepreferred stock 1,742,500...$490K Common stock, 0.001 parvalue 150,000,000...$65K Total liabilities$145,727K Series c 6 superdividend redeemable...$1,723K Borrowing and accruedinterest under...$101,033K Convertible notes payableand accrued...$32,702K Total currentliabilities$8,030K Derivative liabilities(note 6)$3,962K Accrued expenses$4,722K Accounts payable$3,245K Accrued dividendspayable$63K

GALECTIN THERAPEUTICS INC (GALT)

GALECTIN THERAPEUTICS INC (GALT)